BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35453444)

  • 1. Oxidative Stress Markers Are Associated with a Poor Prognosis in Patients with Pancreatic Cancer.
    Ortega MA; Fraile-Martinez O; Pekarek L; García-Montero C; Alvarez-Mon MA; Castellanos AJ; García-Honduvilla N; Buján J; Alvarez-Mon M; Sáez MA; Guijarro LG; Asúnsolo A
    Antioxidants (Basel); 2022 Apr; 11(4):. PubMed ID: 35453444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic role of IRS-4 in the survival of patients with pancreatic cancer.
    Ortega MA; Pekarek L; Garcia-Montero C; Fraile-Martinez O; Saez MA; Asúnsolo A; Alvarez-Mon MA; Monserrat J; Coca S; Toledo-Lobo MV; García-Honduvilla N; Albillos A; Buján J; Alvarez-Mon M; Guijarro LG
    Histol Histopathol; 2022 May; 37(5):449-459. PubMed ID: 35137378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated tissue expression of RANKL and RANK is associated with poorer survival rates in pancreatic cancer patients.
    Ortega MA; Jiménez-Álvarez L; Fraile-Martinez O; Garcia-Montero C; De León-Oliva D; Toledo-Lobo MDV; Palacios E; Granado P; Esteban A; Guijarro LG; Pekarek L; Asúnsolo Á; López-González L; Bujan J; García-Honduvilla N; Álvarez-Mon M; Saez MA; Díaz-Pedrero R
    Histol Histopathol; 2023 Dec; ():18700. PubMed ID: 38230588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated preoperative levels of CA 19-9 and CA 125 predicts overall survival time in the pancreatic adenocarcinoma. Single institution series.
    Hogendorf P; Skulimowski A; Durczyński A; Kumor A; Poznańska G; Poznańska A; Oleśna A; Rut J; Øvereng Juliebø S; Szmiel A; Strzelczyk J
    Pol Przegl Chir; 2020 Apr; 92(3):32-38. PubMed ID: 32759395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of site-specific metastases in pancreatic adenocarcinoma: A Surveillance Epidemiology and End Results database analysis.
    Oweira H; Petrausch U; Helbling D; Schmidt J; Mannhart M; Mehrabi A; Schöb O; Giryes A; Decker M; Abdel-Rahman O
    World J Gastroenterol; 2017 Mar; 23(10):1872-1880. PubMed ID: 28348494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of B7-H4 expression in matched primary pancreatic cancer and liver metastases.
    Qian Y; Sang Y; Wang FX; Hong B; Wang Q; Zhou X; Weng T; Wu Z; Zheng M; Zhang H; Yao H
    Oncotarget; 2016 Nov; 7(44):72242-72249. PubMed ID: 27750217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretherapeutic evaluation of patients with upper gastrointestinal tract cancer using endoscopic and laparoscopic ultrasonography.
    Mortensen MB
    Dan Med J; 2012 Dec; 59(12):B4568. PubMed ID: 23290296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
    Zhang X; Wang Y; A G; Qu C; Chen J
    Front Immunol; 2021; 12():721030. PubMed ID: 34531868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TNIK serves as a novel biomarker associated with poor prognosis in patients with pancreatic cancer.
    Zhang Y; Jiang H; Qin M; Su X; Cao Z; Wang J
    Tumour Biol; 2016 Jan; 37(1):1035-40. PubMed ID: 26269113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of eight immune gene signatures in pancreatic cancer patients.
    Wang W; Xu Z; Wang N; Yao R; Qin T; Lin H; Yue L
    BMC Med Genomics; 2021 Feb; 14(1):42. PubMed ID: 33546693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of YKL-40 Predicts Poor Prognosis in Patients Undergoing Curative Resection of Pancreatic Cancer.
    Chen HT; Zheng JM; Zhang YZ; Yang M; Wang YL; Man XH; Chen Y; Cai QC; Li ZS
    Pancreas; 2017 Mar; 46(3):323-334. PubMed ID: 28099248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High expression of vascular endothelial growth factor predicts early recurrence and poor prognosis after curative resection for ductal adenocarcinoma of the pancreas.
    Niedergethmann M; Hildenbrand R; Wostbrock B; Hartel M; Sturm JW; Richter A; Post S
    Pancreas; 2002 Aug; 25(2):122-9. PubMed ID: 12142733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New-Onset or Exacerbation of Diabetes Mellitus Is a Clue to the Early Diagnosis of Pancreatic Cancer.
    Takikawa T; Kikuta K; Kume K; Hamada S; Miura S; Yoshida N; Hongo S; Tanaka Y; Matsumoto R; Sano T; Ikeda M; Iseki M; Unno M; Masamune A
    Tohoku J Exp Med; 2020 Dec; 252(4):353-364. PubMed ID: 33342915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of prognostic factors associated with early mortality after surgical resection for pancreatic cancer--under-analysis of cumulative survival curve.
    Takamori H; Hiraoka T; Kanemitsu K; Tsuji T; Hamada C; Baba H
    World J Surg; 2006 Feb; 30(2):213-8. PubMed ID: 16425074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different clinical presentations of metachronous pulmonary metastases after resection of pancreatic ductal adenocarcinoma: Retrospective study and review of the literature.
    Lovecek M; Skalicky P; Chudacek J; Szkorupa M; Svebisova H; Lemstrova R; Ehrmann J; Melichar B; Yogeswara T; Klos D; Vrba R; Havlik R; Mohelnikova-Duchonova B
    World J Gastroenterol; 2017 Sep; 23(35):6420-6428. PubMed ID: 29085191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of biomarkers for pancreatic cancer-associated new-onset diabetes to pancreatic cancer screening.
    Zhang Z; Qin W; Sun Y
    Pathol Res Pract; 2018 Dec; 214(12):1923-1928. PubMed ID: 30477640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and Prognostic Value of Indoleamine 2,3-dioxygenase in Pancreatic Cancer.
    Zhang T; Tan XL; Xu Y; Wang ZZ; Xiao CH; Liu R
    Chin Med J (Engl); 2017 Mar; 130(6):710-716. PubMed ID: 28303855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Value of combined therapy in pancreatic cancer with a poor prognosis: analysis of 233 clinical cases].
    Wang Y; Zhao P; Wang CF; Shan Y; Zhao DB; Tian YT; Sun YM; Che X; Zhang JW
    Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(34):2381-5. PubMed ID: 20137689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic factors of pancreatic cancer can be different according to clinical stages.
    Kim YJ; Seo DW; Pack KM; Jeong E; Kim SC; Han DJ; Lee SS; Lee SK; Kim MH
    Korean J Gastroenterol; 2008 Mar; 51(3):181-9. PubMed ID: 18451692
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.